Two critical characteristics of breast cancer that are important to treatment can be identified by measuring gene expression in the tumor, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in Lancet Oncology online. Researchers developed and validated a new genomic microarray test that identifies whether a [...]
Filed under: Affymetrix, bioinformatics, cancer, cancer microarray, clinical diagnostics, clinical microarray, custom microarray, drug development, drug discoverry, gene expression, genetics, genotyping, Hormone replacement and Genetics, hormone replacement therapy, microarray, microarray for clinical diagnostics, Pharmacogenomics | Leave a Comment »
